Published in J Invest Dermatol on February 01, 1984
Lack of effect of topical indomethacin on psoriasis. Br J Clin Pharmacol (1987) 1.42
Leukotrienes in inflammation. Agents Actions (1986) 1.20
Leukotrienes in the sputum and urine of cystic fibrosis children. Br J Clin Pharmacol (1990) 1.10
In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORγt and IL-17. J Invest Dermatol (2013) 0.91
Aphasia with elation, hypermusia, musicophilia and compulsive whistling. J Neurol Neurosurg Psychiatry (1984) 0.90
The inflammatory response of rabbit skin to topical arachidonic acid and its pharmacological modulation. Br J Pharmacol (1986) 0.88
Pharmacokinetics and pharmacodynamics of the leukotriene B4 receptor antagonist CP-105,696 in man following single oral administration. Br J Clin Pharmacol (1998) 0.87
Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis. Br J Clin Pharmacol (1986) 0.86
Effect of leukotriene B4 and prostaglandin E2 on the adhesion of lymphocytes to endothelial cells. Clin Exp Immunol (1990) 0.86
Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway. Arch Dermatol Res (1992) 0.86
Inhibition of ionophore-stimulated leukotriene B4 production in human leucocytes by monohydroxy fatty acids. Br J Pharmacol (1985) 0.84
The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin. Arch Dermatol Res (1991) 0.80
Inhibition of leucotriene B4 synthesis by BW 755c does not reduce polymorphonuclear leucocyte (PMNL) accumulation induced by monosodium urate crystals. Ann Rheum Dis (1988) 0.80
Leukotriene B4 and platelet-activating factor in human skin. Arch Dermatol Res (1992) 0.80
Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions. Arch Dermatol Res (1987) 0.78
The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils. Can J Vet Res (1990) 0.78
Chemotactic lipoxygenase products in sera from patients with psoriasis. Arch Dermatol Res (1986) 0.78
Perspectives in corticosteroid research. Drugs (1988) 0.77
Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin. Arch Dermatol Res (1987) 0.76
LTA4 hydrolase in human skin: decreased activity, but normal concentration in lesional psoriatic skin. Evidence for different LTA4 hydrolase activity in human lymphocytes and human skin. Arch Dermatol Res (1996) 0.75
The in vitro 5-lipoxygenase and cyclo-oxygenase inhibitor L-652,343 does not inhibit 5-lipoxygenase in vivo in human skin. Br J Clin Pharmacol (1988) 0.75
Leukotriene B4 enhances adherence of human polymorphonuclear leukocytes to dermal microvascular endothelial cells in vitro. Arch Dermatol Res (1988) 0.75
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med (2013) 8.89
Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev (1997) 5.21
Elicitation of selective T and B lymphocyte responses by cell surface binding ligands. Transplant Rev (1972) 5.10
Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci U S A (1981) 4.50
Functional analysis of murine and human B lymphocyte subsets. Transplant Rev (1975) 3.69
Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens. J Exp Med (1974) 3.39
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer (1982) 2.71
Evolution of ocean temperature and ice volume through the mid-Pleistocene climate transition. Science (2012) 2.59
Thrombophilia in pregnancy: a systematic review. Br J Haematol (2006) 2.33
In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature (1993) 2.19
Responses of skin blood vessels to bradykinin, histamine and 5-hydroxytryptamine. J Physiol (1967) 2.13
Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med (1992) 2.07
Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. Am J Epidemiol (2006) 2.02
Community dermatology. BMJ (1993) 1.94
God, gays, and health care provision. Am J Dis Child (1992) 1.93
Ozone depletion and cancer risk. Lancet (1987) 1.93
Patterns of gene expression and the cellular origins of human leukaemias. Biochim Biophys Acta (1978) 1.89
Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis. Lancet (1979) 1.87
Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9. J Biol Chem (1982) 1.84
Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol (2008) 1.80
P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med (1981) 1.79
Diagnostic accuracy and appropriateness of general practitioner referrals to a dermatology out-patient clinic. Br J Dermatol (1996) 1.78
Loops, lineage, and leukemia. Cell (1998) 1.73
Abelson virus-transformed haematopoietic cell lines with pre-B-cell characteristics. Nature (1979) 1.66
Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol (1990) 1.64
Ligand-induced redistribution of lymphocyte membrane ganglioside GM1. Nature (1975) 1.57
Interrupted time-series analysis and its application to behavioral data. J Appl Behav Anal (1980) 1.56
Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost (2002) 1.52
Guidelines on the use and monitoring of heparin. Br J Haematol (2006) 1.51
Acute lymphoblastic leukaemia associated antigen. IV. Expression on non-leukaemic 'lymphoid' cells. Leuk Res (1980) 1.50
Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci U S A (1998) 1.50
High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol (1994) 1.45
Inhibition of prostacyclin release by endothelial binding anticardiolipin antibodies in thrombosis-prone patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol (1994) 1.45
Probing two-electron dynamics of an atom. Science (2004) 1.43
Value of pharmacy services: perceptions of consumers, physicians, and third party prescription plan administrators. Am Pharm (1990) 1.42
Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost (1997) 1.41
Pathogenesis of chronic urticaria. Clin Exp Allergy (2009) 1.39
Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood (1999) 1.39
Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption. Eur J Haematol (1992) 1.39
Assessing protective effect of sunscreen products. BMJ (1991) 1.38
Radiation limits. Nature (1989) 1.38
Receptor for transferrin may be a "target" structure for natural killer cells. Proc Natl Acad Sci U S A (1983) 1.37
The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermatol (1984) 1.35
Histogenesis of Kaposi's sarcoma in patients with and without acquired immune deficiency syndrome (AIDS). J Clin Pathol (1986) 1.34
Small intestinal transit in diabetics. Br Med J (1976) 1.29
Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Blood (2000) 1.29
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess (2006) 1.27
Urticaria and vasculitis: a continuum of histological and immunopathological changes. Br J Dermatol (1983) 1.26
Clinical implementation of a Monte Carlo treatment planning system. Med Phys (1999) 1.25
Expression of human transferrin receptor is controlled by a gene on chromosome 3: assignment using species specificity of a monoclonal antibody. Somatic Cell Genet (1982) 1.23
High prevalence of iliofemoral venous thrombosis with severe groin infection among injecting drug users in North East Scotland: successful use of low molecular weight heparin with antibiotics. Postgrad Med J (2000) 1.23
Distribution of airborne mouse allergen in a major mouse breeding facility. J Allergy Clin Immunol (1994) 1.23
Leukemia-associated antigens in man. J Natl Cancer Inst (1975) 1.20
Inadequacies in the postnatal management of fetomaternal alloimmune thrombocytopenia (FMAIT). Br J Haematol (1999) 1.17
Hepatic function tests: postoperative changes with halothane or diethyl ether anesthesia. Mayo Clin Proc (1966) 1.16
Isolation of cDNA clones for the human transferrin receptor. EMBO J (1983) 1.16
Antigenic and enzymatic phenotypes of the pre-B subclass of acute lymphoblastic leukaemia. Leuk Res (1979) 1.16
The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc Natl Acad Sci U S A (1995) 1.14
bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. Blood (1986) 1.14
An immunocytochemical assessment of 19 cases of cutaneous angiosarcoma. Histopathology (1996) 1.14
Left superior vena cava: revisited. Eur Heart J Cardiovasc Imaging (2012) 1.13
Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome. Cancer (1991) 1.12
Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene (1997) 1.11
Legg-Calvé-Perthes disease. Long-term evaluation of non-containment treatment. J Bone Joint Surg Am (1980) 1.10
Overt versus covert assessment of observer reliability. Child Dev (1984) 1.09
Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res (1997) 1.09
A Monte Carlo dose calculation tool for radiotherapy treatment planning. Phys Med Biol (2002) 1.08
Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases. Br J Haematol (1983) 1.07
Case report: Congenital cystic adenomatoid malformation of an entire lung in a 33-year-old man: a case report and review of the literature. Br J Radiol (2008) 1.07
Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet (1987) 1.07
Expression of cell-surface HLA-DR, HLA-ABC and glycophorin during erythroid differentiation. Nature (1981) 1.07
Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis. Clin Exp Immunol (1989) 1.07
Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology. J Clin Pathol (1993) 1.06
Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia. Cancer Res (1999) 1.06
Establishment and characterization of a new leukaemic T-cell line (Peer) with an unusual phenotype. Int J Cancer (1980) 1.06
Stimulation of von Willebrand factor antigen release by immunoglobulin from thrombosis prone patients with systemic lupus erythematosus and the anti-phospholipid syndrome. Br J Rheumatol (1993) 1.06
Phenotypes of 'null' lymphoid cells in human blood. Scand J Immunol (1979) 1.02
Genetic stability of human embryonic stem cells: A first-step toward the development of potential hESC-based systems for modeling childhood leukemia. Leuk Res (2008) 1.02
Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations. Clin Exp Immunol (1988) 1.01
The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. Atherosclerosis (1985) 1.01
Prostaglandins as mediators of bone resorption in renal and breast tumours. Clin Sci (Lond) (1980) 0.99
Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome. Br J Haematol (1982) 0.99
Levels of arachidonic acid and its metabolites in the skin in human allergic and irritant contact dermatitis. Br J Dermatol (1984) 0.99
Diversity of cell surface polypeptides that are recognized by heteroantisera to human T cells. J Immunol (1980) 0.98
Coagulation abnormalities and cerebral infarction. J Neurol Neurosurg Psychiatry (1993) 0.98
Tomlinson and the BMA. BMJ (1993) 0.98
The procoagulant potential of environmental particles (PM10). Occup Environ Med (2005) 0.98
Lupus erythematosus profundus with partial C4 deficiency responding to thalidomide. Br J Dermatol (1991) 0.98
Monoclonal antibody to ganglioside GQ discriminates between haemopoietic cells and infiltrating neuroblastoma tumour cells in bone marrow. Int J Cancer (1981) 0.98
The detection of endothelial cell antigens in cutaneous tissue using methacarn and periodate lysine paraformaldehyde fixation. J Immunol Methods (1986) 0.97
Tufted haemangioma responding to high-dose systemic steroids: a case report and review of the literature. Clin Exp Dermatol (1994) 0.97
Rare case of heart failure caused by compression of the left atrium by a thoracic aortic aneurysm. Heart (2004) 0.97
Fixed drug eruption (phenolphthalein). Evidence for a blood-borne mediator. Arch Dermatol (1972) 0.97
Monoclonal origin of concordant T-cell malignancy in identical twins. Blood (1997) 0.97
Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and C-erbB-2. Bioorg Med Chem Lett (2001) 0.96
Pharmacological studies of anthralin erythema. Br J Dermatol (1981) 0.96
A one-centre prospective audit of peri- and postoperative blood loss and transfusion practice in patients undergoing hip or knee replacement surgery. Ann R Coll Surg Engl (2000) 0.96